Induction of LaborCookNCT06983535
Comparing Outpatient and Inpatient Use of a Cervical Balloon for Starting Labor in Low-Risk Pregnancies.
A study testing cervical balloon catheter in people with Induction of Labor, run by Ziekenhuis Oost-Limburg at 4 sites in Belgium.
Trial summary
Why was this study done? About 20-30% of pregnancies involve labor being started artificially, known as induction. One way to do this is with a balloon catheter placed in the cervix, which helps prepare the body for labor. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Induction of Labor
- What is being tested?
- cervical balloon catheter
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 358 participants
- Where
- 4 sitesBelgium
- Study dates
- 15 Aug 2016to 1 Feb 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- women >18 years of age with singleton pregnancies, cephalic presentation and a unfavourable cervix requiring priming (Bishop Score ≤ 6) that needed an IOL for low risk indications: post-term, macrosomia, patient's preference (> 38 0/7 weeks of gestational age).
Who cannot join
- : multiple pregnancies, preterm premature rupture of membranes (pPROM), foetal growth restriction (FGR), placenta-accreta spectrum (PAS), previous C-Section(s), non-cephalic presentation, gestational diabetes, hypertensive disorders of pregnancy, living at >60 minutes from the hospital, any other maternal or foetal morbidity, any other contraindication to vaginal birth.
Trial locations and contacts
4 sites in 1 country.
Belgium4 sites
University Hospitals Antwerp
Antwerp, Antwerp, 2000
AZ Sint Lucas
Bruges, West-Vlaanderen, 8000
Ziekenhuis Oost-Limburg
Genk, Limburg, 3600
Jessa Ziekenhuis
Hasselt, Limburg, 3500
About this study
Official title: Induction of Labor (IOL) Using Cervical Double-balloon (Cook Catheter) in Outpatient Versus Inpatient Setting (COOK Study): a Multicentre, Randomised Controlled Trial.
Why was this study done? About 20-30% of pregnancies involve labor being started artificially, known as induction. One way to do this is with a balloon catheter placed in the cervix, which helps prepare the body for labor. This mechanical method works just as well as using medication but may be safer for the baby, as it reduces the chances of the womb contracting too much (which can cause stress to the baby). Because it's safe and simple, this method could possibly be done at home instead of in the hospital.
What was the aim of the study? The researchers wanted to compare how safe and effective this balloon method is when used at home (outpatient) versus in the hospital (inpatient). They also wanted to know how satisfied women were with each approach.
Read more
How was the study done? The study took place at four hospitals in Belgium between 2017 and 2023. It included women with healthy low risk pregnancies who were scheduled for induction for non-urgent reasons, such as being past their due date, having a large baby, or by personal choice after 38 weeks of pregnancy.
The women were randomly placed into two groups:
Outpatient setting: going home after balloon placement.
Inpatient setting: staying in the hospital after balloon placement<
The main thing researchers measured was whether the baby's heart rate pattern (checked by CTG monitoring) was abnormal after 12 hours. They also looked at how the baby was born (vaginal birth or C-section), how long labor took, whether additional medicine was needed, pain management, and how satisfied the mothers were with the process.
Read the detailed description
Study Design and Approval
This was a randomised controlled trial - a scientific study designed to compare two groups as fairly as possible. It took place in four hospitals in Belgium:
Ziekenhuis Oost-Limburg (ZOL), Genk
AZ Sint-Lucas, Brugge
Jessa Ziekenhuis, Hasselt
University Hospital Antwerp (UZA), Antwerp
The study ran from May 2017 to November 2023. It was carefully reviewed and approved by the Ethics Committee of ZOL Genk and the review boards of the other hospitals to make sure it followed strict ethical and safety standards.
Who Could Take Part?
Women were eligible to join the study if they:
Were over 18 years old
Were pregnant with just one baby
Had a baby in the head-down (cephalic) position
Had a Bishop Score of 6 or less (indicating the cervix wasn't ready for labor)
Needed their labor to be induced for low-risk reasons, such as:
Being past their due date (post-term)
Suspected large baby (macrosomia)
Personal request to induce labor after 38 weeks of pregnancy
Women were not allowed to join the study if they had any of the following:
Twins or more (multiple pregnancy)
Preterm premature rupture of membranes (water breaking too early)
A baby not growing well (fetal growth restriction)
A condition called placenta accreta spectrum (PAS)
A previous cesarean section
Baby not in head-down position
Gestational diabetes or high blood pressure during pregnancy
Lived more than 60 minutes away from the hospital
Any other health issues (maternal or fetal) or reason that made vaginal birth unsafe
How Were Women Assigned to Groups? Women were told about the study by their doctor in the days leading up to labor induction. On the day of induction, a hospital doctor checked if they met the criteria. If they did, the woman was asked to sign a consent form to take part in the study.
Once enrolled, each woman was randomly assigned to one of two groups:
Inpatient group - stayed in the hospital after balloon insertion
Outpatient group - went home after balloon insertion
The randomisation was done using a computer program, so neither the doctors nor patients could influence which group they were placed into. Because it was obvious who went home and who stayed, this study was not blinded.
The Induction Procedure All four hospitals had experience using mechanical methods to start labor. Before the study began, all staff received a brief training guide to ensure the procedure was done the same way in every hospital.
How the Balloon Was Inserted:
A double-balloon catheter (Cook balloon) was gently inserted into the cervix using a special tool under direct view with a vaginal speculum.
The lower balloon (inside the uterus) was first filled with 20 ml of saline.
The balloon was pulled back so that it rested properly in the cervix.
Then both balloons (one inside the uterus and one in the vagina) were gradually filled with saline up to 80 ml each.
The catheter was taped to the woman's thigh to keep it in place, but no tension or pulling was applied.
After insertion, each woman was monitored for 2 hours using CTG to check the baby's heart rate and any contractions.
If the CTG after balloon insertion was not normal (e.g., slow heartbeat, signs of stress), the woman stayed in the hospital, even if she was in the outpatient group.
Outpatient Group: Going Home If the CTG was normal, women in the outpatient group went home with the balloon still in place and were asked to return to the hospital 12 hours later, unless one of the following happened: their water broke (spontaneous rupture of membranes), they started having strong or painful contractions, the balloon came out or moved, they experienced non-tolerable pain or felt anxious, they simply didn't want to go home.
Before going home, every woman was given clear, written instructions about: when to come back early, what warning signs to look for, how to call the hospital, they also received a follow-up call from the doctor on duty 1-2 hours after leaving, to check how they were doing.
After 12 Hours: Balloon Removal and Next Steps. Twelve hours after the balloon was placed (or sooner, if needed), the balloon was removed. At that time the Bishop Score was checked again to see if the cervix had softened or opened. A new CTG was performed to make sure the baby was doing well.
What happened next depended on how the cervix looked: if the cervix was still not ready (Bishop Score ≤ 6):
→ Labor was continued using prostaglandins (a medication to soften the cervix)
If the cervix was ready (Bishop Score > 6) and effaced (thinned out):
→ Labor was started by breaking the water (amniotomy) and giving oxytocin to strengthen contractions
If the cervix was open but not thinned, doctors often chose oral or vaginal prostaglandins instead of breaking the water.
All clinical details were recorded by trained hospital staff.
Primary Outcome (Main Focus):
The baby's wellbeing as seen on the CTG (heart rate monitor) right after the balloon was inserted and again when it was removed (or sooner if problems occurred).
Secondary Outcomes (Other Important Measures):
- Maternal Clinical Outcomes: How the baby was delivered (normal, assisted with vacuum or forceps, cesarean) Pain relief used (e.g., paracetamol, pethidine, epidural) Use of labor medications like oxytocin
- Process Outcomes: How long the entire induction process took: From hospital admission to discharge From balloon placement to delivery From balloon removal to delivery
- Maternal Satisfaction: Assessed using a detailed 16-question survey sent by email 1-2 days after delivery Topics included overall experience, comfort, timing, and whether they'd choose the same method again
- Maternal Health Concerns:
Possible complications like:
Uterine hyperstimulation (too many contractions)
Placental abruption (placenta detaching early)
Infections needing antibiotics
Doctors also recorded why some women needed C-sections or assisted births.
- Conditions
- Induction of Labor
- Being tested
- cervical balloon catheter
- Keywords
- induction of labor, cervical ripening, balloon catheter
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cervical balloon catheterDevice
Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter
| Study group | Role | What they receive |
|---|---|---|
| Inpatient | Active comparator | Patient in this arm were randomized to stay in the hospital during cervical balloon ripening Receives: Device: cervical balloon catheter |
| Outpatient | Active comparator | Patients in this arm were randomized to ambulant home setting during cervical ripening Receives: Device: cervical balloon catheter |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fetal wellbeing
The primary outcome was foetal wellbeing assessed by cardiotocography (CTG) immediately after balloon insertion and balloon removal (12 hours after insertion). The CTG could be normal or not normal. The CTG was reported as not normal in case of a baseline rise, decelerations (even if they were not repeated decelerations) or decreased variability. The second CTG assessment was performed earlier in case of vaginal bleeding, fluid loss, onset of regular painful contractions, balloon expulsion or in any other case judged clinically relevant by the obstetrician
Measured: 12 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 May 2025
- Study start15 Aug 2016
- Primary completion15 Nov 2023
- Study completion1 Feb 2024
Why it stopped: Slow inclusion rate
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Induction of LaborStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 358 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ziekenhuis Oost-Limburg
- Sponsor type
- University, hospital or other
- Collaborators
- AZ Sint-Lucas Brugge, University Hospital, Antwerp, Jessa Hospital
- Responsible party
- Sponsor
- Investigators
- Zoe Pieters, Study chair, Data Science Institute, Hasselt University, Diepenbeek, Belgium.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06983535
- Sponsor's protocol ID
- GYN2016.01
- Acronym
- Cook
- Status last verified
- May 2025
- First submitted
- 24 Apr 2025
- Last updated
- 21 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Yes: Data regarding the different outcomes
Publications
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Caldwell DM. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2016 Aug;123(9):1462-70. doi: 10.1111/1471-0528.13981. Epub 2016 Mar 22.
PubMed 27001034
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Induction of Labor (IOL) Using Cervical Double-balloon (Cook Catheter) in Outpatient Versus Inpatient Setting (COOK Study): a Multicentre, Randomised Controlled Trial.
- ClinicalTrials.gov ID
- NCT06983535
- Acronym / sponsor ID
- Cook / GYN2016.01
- Conditions
- Induction of Labor
- Keywords
- induction of labor, cervical ripening, balloon catheter
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Slow inclusion rate
- Enrolment
- 358 participants (actual)
- Lead sponsor
- Ziekenhuis Oost-LimburgUniversity, hospital or other
- Collaborators
- AZ Sint-Lucas Brugge, University Hospital, Antwerp, Jessa Hospital
- Study start
- 15 Aug 2016 (actual)
- Primary completion
- 15 Nov 2023 (actual)
- Study completion
- 1 Feb 2024 (actual)
- First posted
- 21 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Why was this study done? About 20-30% of pregnancies involve labor being started artificially, known as induction. One way to do this is with a balloon catheter placed in the cervix, which helps prepare the body for labor. This mechanical method works just as well as using medication but may be safer for the baby, as it reduces the chances of the womb contracting too much (which can cause stress to the baby). Because it's safe and simple, this method could possibly be done at home instead of in the hospital.
What was the aim of the study? The researchers wanted to compare how safe and effective this balloon method is when used at home (outpatient) versus in the hospital (inpatient). They also wanted to know how satisfied women were with each approach.
How was the study done? The study took place at four hospitals in Belgium between 2017 and 2023. It included women with healthy low risk pregnancies who were scheduled for induction for non-urgent reasons, such as being past their due date, having a large baby, or by personal choice after 38 weeks of pregnancy.
The women were randomly placed into two groups:
Outpatient setting: going home after balloon placement.
Inpatient setting: staying in the hospital after balloon placement<
The main thing researchers measured was whether the baby's heart rate pattern (checked by CTG monitoring) was abnormal after 12 hours. They also looked at how the baby was born (vaginal birth or C-section), how long labor took, whether additional medicine was needed, pain management, and how satisfied the mothers were with the process.
Detailed description
Study Design and Approval
This was a randomised controlled trial - a scientific study designed to compare two groups as fairly as possible. It took place in four hospitals in Belgium:
Ziekenhuis Oost-Limburg (ZOL), Genk
AZ Sint-Lucas, Brugge
Jessa Ziekenhuis, Hasselt
University Hospital Antwerp (UZA), Antwerp
The study ran from May 2017 to November 2023. It was carefully reviewed and approved by the Ethics Committee of ZOL Genk and the review boards of the other hospitals to make sure it followed strict ethical and safety standards.
Who Could Take Part?
Women were eligible to join the study if they:
Were over 18 years old
Were pregnant with just one baby
Had a baby in the head-down (cephalic) position
Had a Bishop Score of 6 or less (indicating the cervix wasn't ready for labor)
Needed their labor to be induced for low-risk reasons, such as:
Being past their due date (post-term)
Suspected large baby (macrosomia)
Personal request to induce labor after 38 weeks of pregnancy
Women were not allowed to join the study if they had any of the following:
Twins or more (multiple pregnancy)
Preterm premature rupture of membranes (water breaking too early)
A baby not growing well (fetal growth restriction)
A condition called placenta accreta spectrum (PAS)
A previous cesarean section
Baby not in head-down position
Gestational diabetes or high blood pressure during pregnancy
Lived more than 60 minutes away from the hospital
Any other health issues (maternal or fetal) or reason that made vaginal birth unsafe
How Were Women Assigned to Groups? Women were told about the study by their doctor in the days leading up to labor induction. On the day of induction, a hospital doctor checked if they met the criteria. If they did, the woman was asked to sign a consent form to take part in the study.
Once enrolled, each woman was randomly assigned to one of two groups:
Inpatient group - stayed in the hospital after balloon insertion
Outpatient group - went home after balloon insertion
The randomisation was done using a computer program, so neither the doctors nor patients could influence which group they were placed into. Because it was obvious who went home and who stayed, this study was not blinded.
The Induction Procedure All four hospitals had experience using mechanical methods to start labor. Before the study began, all staff received a brief training guide to ensure the procedure was done the same way in every hospital.
How the Balloon Was Inserted:
A double-balloon catheter (Cook balloon) was gently inserted into the cervix using a special tool under direct view with a vaginal speculum.
The lower balloon (inside the uterus) was first filled with 20 ml of saline.
The balloon was pulled back so that it rested properly in the cervix.
Then both balloons (one inside the uterus and one in the vagina) were gradually filled with saline up to 80 ml each.
The catheter was taped to the woman's thigh to keep it in place, but no tension or pulling was applied.
After insertion, each woman was monitored for 2 hours using CTG to check the baby's heart rate and any contractions.
If the CTG after balloon insertion was not normal (e.g., slow heartbeat, signs of stress), the woman stayed in the hospital, even if she was in the outpatient group.
Outpatient Group: Going Home If the CTG was normal, women in the outpatient group went home with the balloon still in place and were asked to return to the hospital 12 hours later, unless one of the following happened: their water broke (spontaneous rupture of membranes), they started having strong or painful contractions, the balloon came out or moved, they experienced non-tolerable pain or felt anxious, they simply didn't want to go home.
Before going home, every woman was given clear, written instructions about: when to come back early, what warning signs to look for, how to call the hospital, they also received a follow-up call from the doctor on duty 1-2 hours after leaving, to check how they were doing.
After 12 Hours: Balloon Removal and Next Steps. Twelve hours after the balloon was placed (or sooner, if needed), the balloon was removed. At that time the Bishop Score was checked again to see if the cervix had softened or opened. A new CTG was performed to make sure the baby was doing well.
What happened next depended on how the cervix looked: if the cervix was still not ready (Bishop Score ≤ 6):
→ Labor was continued using prostaglandins (a medication to soften the cervix)
If the cervix was ready (Bishop Score > 6) and effaced (thinned out):
→ Labor was started by breaking the water (amniotomy) and giving oxytocin to strengthen contractions
If the cervix was open but not thinned, doctors often chose oral or vaginal prostaglandins instead of breaking the water.
All clinical details were recorded by trained hospital staff.
Primary Outcome (Main Focus):
The baby's wellbeing as seen on the CTG (heart rate monitor) right after the balloon was inserted and again when it was removed (or sooner if problems occurred).
Secondary Outcomes (Other Important Measures):
- Maternal Clinical Outcomes: How the baby was delivered (normal, assisted with vacuum or forceps, cesarean) Pain relief used (e.g., paracetamol, pethidine, epidural) Use of labor medications like oxytocin
- Process Outcomes: How long the entire induction process took: From hospital admission to discharge From balloon placement to delivery From balloon removal to delivery
- Maternal Satisfaction: Assessed using a detailed 16-question survey sent by email 1-2 days after delivery Topics included overall experience, comfort, timing, and whether they'd choose the same method again
- Maternal Health Concerns:
Possible complications like:
Uterine hyperstimulation (too many contractions)
Placental abruption (placenta detaching early)
Infections needing antibiotics
Doctors also recorded why some women needed C-sections or assisted births.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Inpatient | Active comparator | Device: cervical balloon catheterPatient in this arm were randomized to stay in the hospital during cervical balloon ripening |
| Outpatient | Active comparator | Device: cervical balloon catheterPatients in this arm were randomized to ambulant home setting during cervical ripening |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- women >18 years of age with singleton pregnancies, cephalic presentation and a unfavourable cervix requiring priming (Bishop Score ≤ 6) that needed an IOL for low risk indications: post-term, macrosomia, patient's preference (> 38 0/7 weeks of gestational age).
Key exclusion criteria (1 listed)
- : multiple pregnancies, preterm premature rupture of membranes (pPROM), foetal growth restriction (FGR), placenta-accreta spectrum (PAS), previous C-Section(s), non-cephalic presentation, gestational diabetes, hypertensive disorders of pregnancy, living at >60 minutes from the hospital, any other maternal or foetal morbidity, any other contraindication to vaginal birth.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cervical balloon catheterPatients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter | Device | Inpatient, Outpatient |
Primary outcome
Fetal wellbeing
Time frame: 12 hours
The primary outcome was foetal wellbeing assessed by cardiotocography (CTG) immediately after balloon insertion and balloon removal (12 hours after insertion). The CTG could be normal or not normal. The CTG was reported as not normal in case of a baseline rise, decelerations (even if they were not repeated decelerations) or decreased variability. The second CTG assessment was performed earlier in case of vaginal bleeding, fluid loss, onset of regular painful contractions, balloon expulsion or in any other case judged clinically relevant by the obstetrician
Results and safety
The study was stopped early (reason given: Slow inclusion rate). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2025.
- Background: PubMed 27001034Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Caldwell DM. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2016 Aug;123(9):1462-70. doi: 10.1111/1471-0528.13981. Epub 2016 Mar 22.
- European Perinatal Health Report: Core Indicators of the Health and Care of Pregnant Women and Babies in Europe from 2015 to 2019. Euro-PeristatLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Data regarding the different outcomes
Related trials for Induction of Labor
Active, not recruiting
Implementation of a Disparities in Labor Outcomes Dashboard
Labor Induction, Cesarean Birth
Recruiting
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
Premature Infants, Bronchopulmonary Dysplasia
RecruitingPhase 3
Preeclampsia Intervention Netherlands
Pre-Eclampsia Onset Less Than 37 Weeks, Pre-Eclampsia
Not yet recruiting
A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia
Adverse Pregnancy Outcomes, Cardiovascular Diseases
Not yet recruiting
Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination
Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Zoe Pieters study chair
Data Science Institute, Hasselt University, Diepenbeek, Belgium.
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing cervical balloon catheter in people with Induction of Labor, run by Ziekenhuis Oost-Limburg at 4 sites in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 21 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Slow inclusion rate). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fetal wellbeing (time frame: 12 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06983535, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2025.